No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Antitrust Litigation Filed Against Alexion in US Regarding Biosimilar Competition to Soliris® (Eculizumab)
On 25 April 2025, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended marketing approval for eight denosumab biosimilars…On 16 April 2025, EmblemHealth, a US nonprofit health insurer, filed a class action complaint in the US District Court for the District of Massachusetts alleging that AstraZeneca subsidiary, Alexion…